経口ペネムとカーバペネム
Sena Sayood1, Elizabeth Neuner2, Rebekah Dumm3
1Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Clinical microbiology reviews
|September 3, 2025
まとめ
新しい経口ペネムおよびカルバペネム抗生物質は,IVの選択肢に似ているが,より簡単な投与を提供します. 新しい市場での 拡大した使用により 様々な感染症の治療が 簡素化されています
科学分野:
- 薬理学について
- 感染症
- 抗菌療法
背景:
- ペネムとカルバペネムの抗生物質は 広範囲の抗菌剤を 提供しています
- 腸内投与は典型的であり,アクセシビリティを制限する.
- 新たに登場する口服薬は 新しい治療法を提供している.
研究 の 目的:
- 新たに入手可能な経口ペネムおよびカルバペネム抗生物質の特性および用途をレビューする.
- 親体経路よりも経口経路の利点を強調する.
- これらの薬剤の臨床的有用性と管理について議論します.
主な方法:
- 口服用ファロペネム,スロペネム,テビペネムに関する既存の文献のレビュー
- 薬理学および薬理動力学的データの分析
- 臨床的有効性,安全性,管理上の考慮事項の評価
主要な成果:
- 経口ペネム (ファロペネム,スロペネム) とカルバペネム (テビペネム) は,親腸投与薬に匹敵する広範囲の活性を示します.
- これらの経口抗生物質は,静脈注射用薬剤と比較して,投与が簡単です.
- これらの経口薬の利用が増加している.
結論:
- 経口ペネムとカルバペネム抗生物質は 抗生物質療法における 重要な進歩です
- 管理が簡単で 広範囲で使えるので 価値のある代替品です
- 抗菌剤の管理は これらの強力な薬剤の使用を最適化するために不可欠です
関連する概念動画
Development of Antibiotic Resistance
197
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
197
Acute Pyelonephritis II: Diagnostic Studies and Management
39
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
39
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
Antimicrobial Proteins
5.0K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
5.0K
Antimicrobial Effectiveness
156
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
156
Pneumonia IV: Management
445
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
445


